Overexpression and large-scale production of recombinant L-methionine-α-deamino-γ-mercaptomethane-lyase for novel anticancer therapy

Protein Expression and Purification

Volumn 9, Issue 2, 1997, Pages 233-245

  Tan, Yuying ^a   Xu, Mingxu ^a   Tan, Xuezhong ^a   Tan, Xiuying ^a   Wang, Xiaoen ^a   Saikawa, Yoshiro ^a   Nagahama, Takeshi ^a   Sun, Xinghua ^a   Lenz, Martin ^a   Hoffman, Robert M ^a  

^a ANTICANCER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; ESCHERICHIA COLI; MUS MUSCULUS; PSEUDOMONAS; PSEUDOMONAS PUTIDA;

EID: 0031106365     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1006/prep.1996.0700     Document Type: Article

References (40)

1. Devita V. T., Hellman S., Rosenberg S. A. CANCER Principles & Practice of Oncology. 1993;Lippincott, Philadelphia. p. 387-389.
2. Mecham J. O., Rowitch D., Wallace C. D., Stern P. H., Hoffman R. M. The metabolic defect of methionine dependence occurs frequently in human tumor cell lines. Biochem. Biophys. Res. Commun. 117:1983;429-434.
3. Halpern B. C., Clark B. R., Hardy D. N., Halpern R. M., Smith R. A. The effect of replacement of methionine by homocysteine on survival of malignant and normal adult mammalian cells in culture. Proc. Natl. Acad. Sci. USA. 71:1974;1133-1136.
4. Naylor S. L., Busby L. L., Klebe R. J. Biochemical selection systems for mammalian cells: The essential amino acids. Somat. Cell Genet. 2:1976;93-111.
5. Kreis W., Goodenow M. Methionine requirement and replacement by homocysteine in tissue cultures of selected rodent and human malignant and normal cells. Cancer Res. 38:1978;2259-2262.
6. 12. Proc. Natl. Acad. Sci. USA. 70:1973;2585-2589.
7. Hoffman R. M. Altered methionine metabolism, DNA methylation, and oncogene expression in carcinogenesis: A review and synthesis. Biochim. Biophys. Acta. 738:1984;49-87.
8. Guo H. Y., Herrera H., Groce A., Hoffman R. M. Expression of the biochemical defect of methionine dependence occurs in fresh patient tumors in primary histoculture. Cancer Res. 53:1993;2479-2483.
9. Hoffman R. M., Erbe R. W. Highin vivo. Proc. Natl. Acad. Sci. USA. 73:1976;1523-1527.
10. Fisskerstrand T., Christensen B., Tysnes O. B., Ueland P. M., Refsum H. Development and reversion of methionine dependence in a human glioma cell line: Relation to homocysteine remethylation and cobalamin status. Cancer Res. 54:1994;4899-4906.
11. Coalson D. W., Mecham J. O., Stern P. H., Hoffman R. M. Reduced availability of endogenously synthesized methionine for S-adenosylmethione formation in methionine-dependent cancer cells. Proc. Natl. Acad. Sci. USA. 79:1982;4248-4251.
12. Tisdale M. J. Effect of methionine replacement by homocysteine on the growth of cells. Cell Biol. Intl. Rep. 4:1980;563-567.
13. Stern P. H., Wallace C. D., Hoffman R. M. Altered methionine metabolism occurs in all members of a set of diverse human tumor cells. J. Cell. Physiol. 119:1984;29-34.
14. Stern P. H., Hoffman R. M. Elevated rates of transmethylation in cell lines from diverse human tumors. In Vitro Cell Biol. 20:1984;663-670.
15. Stern P. H., Mecham J. O., Wallace C. D., Hoffman R. M. Reduced free-methionine in methionine-dependent SV-40 transformed human fibroblasts synthesizing apparently normal amounts of methionine. J. Cell. Physiol. 117:1983;9-14.
16. Nobori T., Szinai I., Amox D., Parker B., Olopade O., Buchhagen D., Carson D. Methylthioadenosine phosphorylase deficiency in human non-small cell lung cancer. Cancer Res. 53:1993;1098-1101.
17. Guo H., Lishko V., Herrera H., Groce A., Kubota T., Hoffman R. M. Therapeutic tumor specific cell-cycle block induced by methionine starvationin vivo. Cancer Res. 53:1993;5676-5679.
18. Stern P. H., Hoffman R. M. Enhancedin vitro. J. Natl. Cancer Inst. 76:1986;629-639.
19. Goseki N., Yamazaki S., Endo M. Antitumor effect of methionine-depleting total parenteral nutrition with doxorubicin administration on Yoshida sarcoma-bearing rats. Cancer. 69:1992;1865-1872.
20. Breillout F., Hadida F., Echinard-Darin P., Lascaux V., Poupon M.-F. Decreased rat rhabdomyosarcoma pulmonary metastases in response to a low methionine diet. Anticancer Res. 7:1987;861-868.
21. Hoffman R. M., Jacobsen S. J. Reversible growth arrest in SV40-transformed human fibroblasts. Proc. Natl. Acad. Sci. USA. 77:1980;7306-7310.
22. Breillout F., Antoinne E., Poupon M.-F. Methionine dependency of malignant tumors: A possible approach for therapy. J. Natl. Cancer Inst. 82:1990;1628-1632.
23. Goseki N., Yamazaki S., Shimojyu K., Kando F., Maruyama M., Endo M., Koike M., Takahashi H. Synergistic effect of methionine-depleting total parenteral nutrition with 5-fluorouracil on human gastric cancer: A randomized, prospective clinical trial. Jpn. J. Cancer Res. 86:1995;484-489.
24. Kreis W., Hession C. Isolation and purification of L-methionine-α-deamino-γ mercaptomethane-lyase (L-methioninase) fromClostridium. Cancer Res. 33:1973;1862-1865.
25. Ito S., Nakamura T., Eguchi Y. Purification and characterization of methoninase fromP. putida. J. Biochem. 79:1976;1263-1272.
26. Nakamura T., Esaki N., Tanaka H., Soda K. Specific labeling of the essential cysteine residue of L-methionine γ-lyase with a cofactor analogue, N-(bromo-acetyl) pyridoxamine phosphate. Biochemistry. 27:1988;1587-1591.
27. Tanaka H., Esaki N., Soda K. Properties of L-methionine γ-lyase fromPseudomonas ovalis. Biochemistry. 16:1977;100-106.
28. Nakamura T., Esaki N., Sugiem K., Beresov T., Tanaka H., Soda K. Purification of bacterial L-methionine-lyase. Anal. Biochem. 138:1984;421-424.
29. Lishko V. K., Lishko O. V., Hoffman R. M. The preparation of endotoxin-free L-methionine-α-deamino-mercaptomethane-lyase (L-methioninase) fromPseudomonas putida. Protein Exp. Purif. 4:1993;529-533.
30. Tan Y., Zavala J. Sr., Xu M., Zavala J. Jr., Hoffman R. M. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients. Anticancer Res., 1996.
31. Lishko V. K., Lishko O. V., Hoffman R. M. Depletion of serum methionine by methioninase in mice. Anticancer Res. 13:1993;1465-1468.
32. Tan Y., Xu M., Sun X., Kubota T., Hoffman R. M. Anticancer efficacy of methioninase in vivo. Anticancer Res. 1996.
33. Inoue H., Inagaki K., Sugimoto M., Esaki N., Soda K., Tanaka H. Structural analysis of the L-methionine γ-lyase gene from Pseudomonas putida. J. Biochem. 117:1995;1120-1125.
34. Hori H., Takabayashi K., Orvis L., Carson D. A., Nobori T. Gene cloning and characterization ofPseudomonas putida. Cancer Res. 56:1996;2116-2122.
35. Sanger F., Nicklen S., Coulson A. R. DNA sequencing with chain terminating inhibitors. Proc. Natl. Acad. Sci. USA. 74:1977;5463-5467.
36. Tabor S. Expression using the T7 RNA polymerase/promoter system. Current Protocols in Molecular Biology. 1990;Greene Publishing and Wiley-Interscience. p. 16.2.1-16.2.11.
37. Weiner M. P., Anderson C., Jerpseth B., Wells S., Johnson-Browne B., Vaillancourt P. Studier pET system vectors and hosts. Strategies Mo. Bio. 7(2):1994;41-43.
38. Sambrook J., Fritsch E., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
39. Bissery M-C., Vrignaud P., Lavelle F. Preclinical profile of Docetaxel (taxotere): Efficacy as a single agent and in combination. Semin. Oncol. 22:1995;3-16.
40. Alexander F. W., Sandmeier E., Mehta P. K., Christen P. Evolutionary relationships among pyridoxal-5′-phosphate-dependent enzymes: Regio-specific α, β and γ families. Eur. J. Biochem. 219:1994;953-960.